OTC · RTNXF
Renalytix Plc
$0.08$0.00 (0.0%)
Renalytix Plc’s quoted price sits in the lower half of its reported 52-week range, 87.52% below the high.
Loading market information…
OTC · THKKF · USD
Stock price, earnings
Quote as of Apr 16, 2024, 01:54 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Think Research Corporation’s quoted price sits in the lower half of its reported 52-week range, 37.24% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Think Research Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Think Research Corporation, operating with its various subsidiaries, specializes in creating, curating, and deploying intelligent Software-as-a-Service (SaaS) solutions for the global healthcare sector, with a presence in Canada, the United States, and beyond. Their extensive range of digital tools is designed to enhance patient care and streamline clinical operations. These offerings include structured order sets that guide care delivery at critical junctures, and eReferrals, which enable physicians to efficiently find and connect patients with specialists directly from their Electronic Medical Record (EMR) systems. The company also offers VirtualCare, empowering healthcare providers and allied professionals to conduct remote consultations as an alternative to traditional in-person appointments. Additionally, their eForms provide real-time data insights for monitoring resident populations, ensuring compliance with signature protocols, and managing overall adherence. The portfolio is rounded out by specialized clinical instruments for managing COVID-19 and dedicated support solutions for long-term care facilities. Think Research Corporation is primarily based in Toronto, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:07 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| $14.32M-13.16% vs estimate |
| Q1 2022 | May 30, 2022 | -$0.08-5.61% vs estimate | $16.16M+2.52% vs estimate |
|---|
| Q1 2022 | May 2, 2022 | -$0.12-9.09% vs estimate | $37.48M+150.05% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.08$0.00 (0.0%)
Renalytix Plc’s quoted price sits in the lower half of its reported 52-week range, 87.52% below the high.
$0.39-$0.00 (-0.39%)
HS GovTech Solutions Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.22% below the high.
$2.74-$0.01 (-0.27%)
Organicell Regenerative Medicine, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.86% below the high.
$0.01-$0.04 (-76.0%)
Antisense Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 84.0% below the high.
$0.22$0.00 (0.0%)
Dignitana AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 1.89% below the high.
$0.33-$0.03 (-8.71%)
Nurosene Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.73% below the high.
A$0.05A$0.00 (0.0%)
Noxopharm Limited’s quoted price sits in the lower half of its reported 52-week range, 55.45% below the high.
CA$0.04-CA$0.01 (-12.5%)
Lifeist Wellness Inc.’s quoted price sits in the lower half of its reported 52-week range, 53.33% below the high.
